Stay updated on APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added to the Study Record History and Revision: v3.5.3 was removed. This reflects an update to the page's revision metadata in the history section.
    Difference
    0.1%
    Check dated 2026-05-15T15:34:10.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The record history page’s revision/version label has been updated from v3.5.2 to v3.5.3, indicating a site/version change rather than a modification to the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T05:47:24.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 to the history. Removed Revision: v3.5.0 from the history.
    Difference
    0.1%
    Check dated 2026-04-17T02:36:51.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 in the record history. Removed Revision: v3.4.3 from the record history.
    Difference
    0.1%
    Check dated 2026-03-19T05:15:49.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    New revision entry v3.4.3 was added to the history, replacing the previous v3.4.2 entry. It reflects a site version update and does not modify trial data or the study record.
    Difference
    0.1%
    Check dated 2026-03-12T01:03:46.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history, and older items (a funding notice and v3.4.1) were removed. These are administrative updates to the page’s revision history rather than to study data or core content.
    Difference
    0.5%
    Check dated 2026-02-11T14:15:21.000Z thumbnail image

Stay in the know with updates to APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page.